Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-013361
Filing Date
2021-04-19
Accepted
2021-04-19 19:34:09
Documents
2
Period of Report
2021-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 3894
2 EXHIBIT 24 brhc10023325_ex24.htm EX-24 9052
  Complete submission text file 0001140361-21-013361.txt   14600
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BOW STREET CAMBRIDGE MA 02138
Business Address
Cherington Charles (Reporting) CIK: 0001448698 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 21835906